Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation

Kidney International

Volumn 58, Issue 2, 2000, Pages 674-683

  Shankland, Stuart J ^a,b   Eitner, Frank ^a,b   Hudkins, Kelly L ^a,b   Goodpaster, Tracy ^a,b   D’agati, Vivette ^a,b   Alpers, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cell cycle; Glomerular podocytes; Kidney; Proliferation; Visceral glomerular epithelial cell

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27;

ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; PODOCYTE; PRIORITY JOURNAL;

EID: 0033864305     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00213.x     Document Type: Article

References (41)

1. Structure and function of podocytes: An update
2. Cell renewal of glomerular cell types in normal rats: An autoradiographic analysis
3. Prolifeative activity of intrinsic cell populations in the normal kidney
4. Progressive renal failure: Inability of podocytes to replicate and the consequences for development of glomerulosclerosis
5. Pathogenesis of membranous nephropathy
6. Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis
7. A frequent pathway to glomerulosclerosis: Deterioration of tuft architecture-podocyte damage-segmental sclerosis
8. Progression of glomerular diseases: Is the podocyte the culprit?
9. The many masks of focal segmental glomerulosclerosis
10. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
11. Idiopathic collapsing focal glomerulosclerosis: A clinicopathologic study
12. Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis
13. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy
14. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy
15. Principles of CDK regulation
16. Cyclin dependent kinase regulation
17. Mammalian G1 cyclins
18. Inhibitors of mammalian G1 cyclin-dependent kinases
19. p21WAF1, a potential mediator of p53 tumor suppression
20. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
21. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
22. Cloning of p27kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals
23. Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwith-Wiedermann syndrome
24. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition
25. The expanding role of cell cycle regulators
26. Expression of the cyclin kinase inhibitor, p27(kip1) in developing and mature human kidney
27. Cell cycle regulation and differentiation in the human podocyte lineage
28. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1
29. Characterization of a panel of novel anti-p21 (WAF1/Cip1) monoclonal antibodies and immunochemical analysis of p21 (WAF1/Cip1) expression in normal human tissues
30. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line
31. The role of p27kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells
32. Expression of p21WAF1/CIP1 in fetal and adult tissues: Simultaneous analysis with Ki-67n and p53
33. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo
34. The cyclin-kinase inhibitor p27(Kip1) safeguards against inflammatory injury
35. Cooperation between the CDK inhibitors p27 (Kip1) and p57 (Kip2) in the control of tissue growth and development
36. Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis
37. The cyclin kinase inhibitor p21(WAF1, CIP1) is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy
38. The cyclin kinase inhibitor p21Cip1/WAF1 limits visceral glomerular epithelial cell proliferation in experimental glomerulonephritis
39. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors